All lobbying filings

WINNING STRATEGIES WASHINGTON

WINNING STRATEGIES WASHINGTON filed a Q2 report for DBV TECHNOLOGIES on July 16, 2026, reporting $30,000 in lobbying income.

Lobbying for DBV TECHNOLOGIES · Pharmaceutical Company

All filings by WINNING STRATEGIES WASHINGTON · Everything DBV TECHNOLOGIES has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 3

DONNA MULLINS

Previously held: CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa
ELIZABETH CONNOLLY

Previously held: Assistant Director of the Office of Public Health, Office of National Drug Control Policy
MICHAEL A MEROLA

Previously held: Deputy CoS, Sen. Torricelli

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Innovation in medical therapies to treat childhood food allergies

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.